iifl-logo

Oxygenta Pharmaceutical Ltd Cash Flow Statement

80.3
(-2.88%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Oxygenta Pharma FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2020Mar-2019Mar-2018Mar-2017

Profit before tax

-9.92

-3.49

-4.47

-5.72

Depreciation

-0.99

-1.01

-0.94

-0.9

Tax paid

0.15

0.23

-0.04

-0.08

Working capital

-1

5.04

-2.12

3.97

Other operating items

Operating

-11.77

0.76

-7.58

-2.73

Capital expenditure

0.52

0.59

0.77

0.53

Free cash flow

-11.25

1.35

-6.8

-2.19

Equity raised

-90.72

-84.21

-75.16

-63.54

Investing

0

0

0

0

Financing

48.26

37.97

34.54

33.19

Dividends paid

0

0

0

0

Net in cash

-53.71

-44.88

-47.43

-32.55

Oxygenta Pharma : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.